Advanced search×

Intensive tuberculosis screening for HIV-infected patients starting antiretroviral therapy in Durban, South Africa.

Ingrid V IV Bassett, Bingxia B Wang, Senica S Chetty, Janet J Giddy, Elena E Losina, Matilda M Mazibuko, Benjamin B Bearnot, Jenny J Allen, Rochelle P RP Walensky, and Kenneth A KA Freedberg

Clin Infect Dis 51(7):823-9 (2010) PMID 20735240 PMCID PMC3204934

The World Health Organization (WHO) recommends cough as the trigger for tuberculosis screening in human immunodeficiency virus (HIV)-infected patients, with acid-fast bacillus (AFB) smear as the initial diagnostic test. Our objective was to assess the yield and cost of a more intensive tuberculosis screening in HIV-infected patients starting antiretroviral therapy (ART) in Durban, South Africa.

Referenced by 1 articles

DOI: 10.1086/656282
Version: za2963e q8zad q8zbb q8zc5 q8zda q8ze5 q8zf2 q8zg7
View PDF

Similar articles you may find interesting…

  1. Systemic lupus erythematosus and HIV infection: a whimsical relationship. Reports of two cases and review of the literature.
    Manuela Carugati, Marco Franzetti, and Agostino Riva

    Clin Rheumatol (2013) PMID 23649483

    We describe two unpredictable cases and provide a review of the literature. Retrospective analysis of the medical records of two HIV-infected patients diagnosed with SLE and admitted at Luigi Sacco Hospital (Milano, Italy). Search of the literature from 1981 to 2012 and review of the cases reported....
    Buy PDF
  2. Assessing main death pathways in T lymphocytes from HIV infected individuals.
    Marta Massanella, Marta Curriu, and Julià Blanco

    Cytometry A (2013) PMID 23650261

    We have developed a simple and fast assay to assess major cell death pathways in lymphocytes isolated from HIV-infected individuals. The combination of three factors: (i) antibody staining to identify CD3(+) CD4(+) and CD3(+) CD8(+) cells, (ii) assessment of mitochondrial and plasma membrane functio...
    Buy PDF
  3. In vitro and in vivo antidermatophytic activity of the dichloromethane-methanol (1:1 v/v) extract from the stem bark of Polyscias fulva Hier...
    Guy Sedar Njateng, Donatien Gatsing, and Jules-Roger Kuiate

    BMC Complement Altern Med 13(1):95 (2013) PMID 23641972

    The results of preclinical in vitro and in vivo evaluations indicate that the extract-oil formulation at 5% may constitute an alternative means to alleviate fungal infections caused by dermatophytes....
    PDF not found